Literature DB >> 9169734

Induction of nitric oxide production by polyosides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta.

V Martin1, A L Kleschyov, J P Klein, A Beretz.   

Abstract

The cardiovascular dysfunctions associated with septic shock induced by gram-negative or gram-positive bacteria (gram-positive or gram-negative septic shock) are comparable. In gram-negative septic shock, lipopolysaccharide (LPS) induces nitric oxide (NO) synthase, which contributes to the vascular hypotension and hyporeactivity to vasoconstrictors. The role of NO in gram-positive septic shock and the nature of the bacterial wall components responsible for the vascular effects of gram-positive bacteria are not well known. This study investigated the vascular effects of cell wall serotype polyosides, rhamnose glucose polymers (RGPs), from Streptococcus mutans, in comparison with lipoteichoic acid (LTA) from Staphylococcus aureus, on the induction of NO synthase activity in the rat aorta. We show that 10 microg of both RGPs and LTA per ml induced hyporeactivity to noradrenaline, L-arginine-induced relaxation, increases of 2.2- and 7.8-fold, respectively, of cyclic GMP production, and increases of 7- and 12-fold in nitrite release. All of these effects appeared after several hours of incubation and were inhibited by N(omega)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthase. Electron paramagnetic resonance spin trapping experiments demonstrated directly that RGPs and LTA induced NO overproduction (four- to eightfold, respectively) in rat aortic rings; this production was inhibited by L-NAME and prevented by dexamethasone. These results demonstrate directly the induction of NO production in vascular tissue by LTA and show that another, chemically different component of gram-positive bacteria can also have these properties. This result suggests that different components of the gram-positive bacterial wall could be implicated in the genesis of cardiovascular dysfunctions observed in gram-positive septic shock.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169734      PMCID: PMC175286          DOI: 10.1128/iai.65.6.2074-2079.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Guanosine 3', 5'-cyclicmonophosphate assay at 10(-15)-mole level.

Authors:  H L Cailla; C J Vannier; M A Delaage
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 3.  Lipoteichoic acids: a new class of bacterial antigen.

Authors:  A J Wicken; K W Knox
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

4.  Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.

Authors:  S J De Kimpe; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

Authors:  S J De Kimpe; M Kengatharan; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Chemical and immunological properties of the type f polysaccharide antigen of Streptococcus mutans.

Authors:  S Hamada; K Gill; H D Slade
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs.

Authors:  A Mülsch; P Mordvintcev; E Bassenge; F Jung; B Clement; R Busse
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

9.  Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes.

Authors:  T R Billiar; R D Curran; B G Harbrecht; J Stadler; D L Williams; J B Ochoa; M Di Silvio; R L Simmons; S A Murray
Journal:  Am J Physiol       Date:  1992-04

10.  Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice.

Authors:  J M Herbert; L Lespy; J P Maffrand
Journal:  Eur J Pharmacol       Date:  1991-12-03       Impact factor: 4.432

View more
  9 in total

1.  Role of serotype-specific polysaccharide in the resistance of Streptococcus mutans to phagocytosis by human polymorphonuclear leukocytes.

Authors:  H Tsuda; Y Yamashita; K Toyoshima; N Yamaguchi; T Oho; Y Nakano; K Nagata; T Koga
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Genes involved in cell wall localization and side chain formation of rhamnose-glucose polysaccharide in Streptococcus mutans.

Authors:  Y Yamashita; Y Tsukioka; K Tomihisa; Y Nakano; T Koga
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

3.  Expression and characterization of streptococcal rgp genes required for rhamnan synthesis in Escherichia coli.

Authors:  Yukie Shibata; Yoshihisa Yamashita; Kazuhisa Ozaki; Yoshio Nakano; Toshihiko Koga
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Recombination between gtfB and gtfC is required for survival of a dTDP-rhamnose synthesis-deficient mutant of Streptococcus mutans in the presence of sucrose.

Authors:  Y Yamashita; K Tomihisa; Y Nakano; Y Shimazaki; T Oho; T Koga
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  A novel gene required for rhamnose-glucose polysaccharide synthesis in Streptococcus mutans.

Authors:  Y Yamashita; Y Shibata; Y Nakano; H Tsuda; N Kido; M Ohta; T Koga
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

6.  Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences.

Authors:  M W Meyer; K Gong; M C Herzberg
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Insertional inactivation of pac and rmlB genes reduces the release of tumor necrosis factor alpha, interleukin-6, and interleukin-8 induced by Streptococcus mutans in monocytic, dental pulp, and periodontal ligament cells.

Authors:  Marc Engels-Deutsch; Annelise Pini; Yoshihisa Yamashita; Yukie Shibata; Youssef Haikel; Marie Schöller-Guinard; Jean-Paul Klein
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis.

Authors:  Matthew T G Holden; Heidi Hauser; Mandy Sanders; Thi Hoa Ngo; Inna Cherevach; Ann Cronin; Ian Goodhead; Karen Mungall; Michael A Quail; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Nicholas J Croucher; Tran Bich Chieu; Nguyen Thi Hoang Mai; To Song Diep; Nguyen Tran Chinh; Michael Kehoe; James A Leigh; Philip N Ward; Christopher G Dowson; Adrian M Whatmore; Neil Chanter; Pernille Iversen; Marcelo Gottschalk; Josh D Slater; Hilde E Smith; Brian G Spratt; Jianguo Xu; Changyun Ye; Stephen Bentley; Barclay G Barrell; Constance Schultsz; Duncan J Maskell; Julian Parkhill
Journal:  PLoS One       Date:  2009-07-15       Impact factor: 3.240

9.  StreptoBase: An Oral Streptococcus mitis Group Genomic Resource and Analysis Platform.

Authors:  Wenning Zheng; Tze King Tan; Ian C Paterson; Naresh V R Mutha; Cheuk Chuen Siow; Shi Yang Tan; Lesley A Old; Nicholas S Jakubovics; Siew Woh Choo
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.